Who
Barry Ticho
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Stoke Therapeutics.
In numbers
- Trades disclosed
- 175
- Buys
- 0
- Sells
- 56
- Bought
- $0
- Sold
- $8.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Mar 2020
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $27K1,051 at $26.16 | filing |
| 1 Sep 2026filed 3 Sep 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $120K3,945 at $30.51 | filing |
| 1 Sep 2026filed 3 Sep 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $50K1,600 at $31.06 | filing |
| 1 Sep 2026filed 3 Sep 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $120K3,945 at $30.51 | filing |
| 1 Sep 2026filed 3 Sep 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $50K1,600 at $31.06 | filing |
| 18 Aug 2026filed 18 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $145K4,525 at $32.01 | filing |
| 18 Aug 2026filed 18 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,857242 at $32.47 | filing |
| 18 Aug 2026filed 18 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $145K4,525 at $32.01 | filing |
| 18 Aug 2026filed 18 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,858242 at $32.47 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STOK Stoke Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STOK Stoke Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $171K5,907 at $28.95 | filing |
| 3 Aug 2026filed 5 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $37K1,269 at $29.45 | filing |
| 3 Aug 2026filed 5 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $171K5,907 at $28.95 | filing |
| 3 Aug 2026filed 5 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $37K1,269 at $29.45 | filing |
| 1 Jul 2026filed 6 Jul 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $219K6,728 at $32.62 | filing |
| 1 Jul 2026filed 6 Jul 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $17K500 at $33.27 | filing |
| 1 Jul 2026filed 6 Jul 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $219K6,728 at $32.62 | filing |
News
Critical Contrast: Stoke Therapeutics (NASDAQ:STOK) vs. MeiraGTx (NASDAQ:MGTX)STOK · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name Barry Ticho; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.